Otsuka Pharmaceutical Development and Commercialization

The US Food and Drug Administration (FDA) has rejected the first medication that combines drugs with a digital sensor that measures medication adherence Read more


What’s hot for 2016? Lu Rahman asks key industry players what they think the key pharma trends will be for the coming year Read more


Aripiprazole has been combined with an ingestible sensor to create a combination product, Abilify, which has New Drug Application (NDA) acceptance from the Food and Drug Administration (FDA) Read more


Pharmaceutical companies will suffer an estimated $65 billion drop in sales by 2019 due to the patent expiries of several leading drugs, according to research and consulting firm GlobalData. Read more

Horizon Discovery Group's CombinatoRx division has been contracted by Otsuka Pharmaceutical Development and Commercialization (OPDC) to perform in vitro cell line screening of certain OPDC development candidate(s). Read more